OBIO
Orchestra BioMed Holdings Inc Com
$2.36
-$0.10(-3.88%)
40
Overall
--
Value
40
Tech
--
Quality
Market Cap
$136.51M
Volume
219.13K
52W Range
$2.37 - $6.50
Target Price
$13.50
Order:
Income Statement
| Metric | Trend | Chart | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|
| REVENUE | |||||
| Total Revenue | $3.5M | $2.8M | $2.6M | ||
| Total Revenue | $3.5M | $2.8M | $2.6M | ||
| COST OF GOODS SOLD | |||||
| Cost of Revenue | $211.0K | $186.0K | $204.0K | ||
| GROSS PROFIT | |||||
| Gross Profit | $3.3M | $2.6M | $2.4M | ||
| OPERATING EXPENSES | |||||
| Operating Expenses | $36.2M | $54.1M | $66.7M | ||
| Research & Development | $21.9M | $33.8M | $42.8M | ||
| Research Expense | $21.9M | $33.8M | $42.8M | ||
| Selling, General & Administrative | $14.0M | $20.3M | $23.9M | ||
| General & Administrative Expenses | $14.0M | $20.3M | $23.9M | ||
| Depreciation & Amortization | $222.0K | $287.0K | $308.0K | ||
| Depreciation & Amortization | $222.0K | $287.0K | $308.0K | ||
| Other Operating Expenses | $-203.0K | $-442.0K | $-341.0K | ||
| OPERATING INCOME | |||||
| Operating income | $-32.7M | $-51.5M | $-64.3M | ||
| EBITDA | $-32.4M | $-46.7M | $-59.7M | ||
| NON-OPERATING ITEMS | |||||
| Interest Expense (Non-Operating) | $-50.0K | $1.4M | $297.0K | ||
| Intinc | $345.1K | $3.8M | $3.4M | ||
| Net Non-Operating Interest Income/Expense | $-50.0K | $3.8M | $3.4M | ||
| Gain on Sale of Securities | $1.0M | $-18.0K | $-68.0K | ||
| Other Income/Expense | $-1.0M | $1.5M | $17.0K | ||
| Other Special Charges | $-2.0M | $-1.4M | $-11.0K | ||
| PRE-TAX INCOME | |||||
| EBIT | $-32.7M | $-47.7M | $-60.7M | ||
| Pre-Tax Income | $-33.6M | $-49.1M | $-61.0M | ||
| NET INCOME | |||||
| Net Income | $-33.6M | $-49.1M | $-61.0M | ||
| Net Income (Continuing Operations) | $-33.6M | $-49.1M | $-61.0M | ||
| Net Income (Discontinued Operations) | $-33.6M | $-49.1M | $-61.0M | ||
| Net Income (Common Stockholders) | $-33.6M | $-49.1M | $-61.0M | ||
| Normalized Income | -- | -- | $-60.4M | ||
| TOTALS | |||||
| Total Expenses | $36.2M | $54.3M | $66.9M | ||
| SHARE & EPS DATA | |||||
| Average Shares Outstanding | $16.4M | $33.2M | $36.8M | ||
| Average Shares Outstanding (Diluted) | $16.4M | $33.2M | $36.8M | ||
| Shares Outstanding | $11.2M | $35.8M | $38.3M | ||
| Basic EPS | $-0.17 | $-1.48 | $-1.66 | ||
| Basic EPS (Continuing Operations) | -- | $-1.48 | $-1.66 | ||
| Diluted EPS | $-0.17 | $-1.48 | $-1.66 | ||
| Diluted EPS (Continuing Operations) | -- | $-1.48 | $-1.66 | ||
| OTHER METRICS | |||||
| Other Gand A | $14.0M | $20.3M | $23.9M | ||
| Other Taxes | $211.0K | -- | -- | ||
| Rent And Landing Fees | $735.0K | $835.0K | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | OBIO | $2.36 | -3.9% | 219.13K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Orchestra BioMed Holdings Inc Com Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW